ArticleScientific reports2026
Enhancing anti-inflammatory activity of Eucalyptus camaldulensis by upregulating secondary metabolites using suspension cultures techniques.
Article in Scientific reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Eucalyptus camaldulensis leaf extract enhances thalidomide efficacy in acute myeloid leukemia cells through modulation of mitochondrial energetics.BMC complementary medicine and therapies · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Eucalyptus camaldulensis Dehn (Family Myrtaceae) is among the most prominent Eucalyptus species, extensively exploited for its anti-inflammatory efficacy. The present study undertakes a comparative phytochemical and pharmacological evaluation of leaf and tissue culture (callus) extracts and their corresponding volatile oils. Methanolic extracts from both plant sources were subjected to liquid chromatography–mass spectrometry (LC/MS), revealing 32 phytoconstituents in leaf extracts and 54 in callus extracts. Identified chemical classes included flavonoids, tannins, coumarins, and phenolic acids, with higher relative abundance in callus-derived extracts. Volatile oil analysis using gas chromatography–mass spectrometry (GC/MS) identified 58 compounds in leaf oil and 52 in callus oil. Quantitative profiling demonstrated a significant elevation in bioactive volatiles within callus oil: 1,8-cineole content showed a 2.1-fold increase compared to leaf oil, and both α-terpineol and sabinene exhibited approximately fourfold increases relative to leaf oil. Bioassays further indicated that callus extracts and volatile oils possess enhanced anti-inflammatory and antioxidant activities, exhibiting higher potency than leaf-derived counterparts. Remarkably, the anti-inflammatory activity of callus volatile oil exceeded that of the standard pharmaceutical agent indomethacin. These findings underscore the potential of in vitro tissue culture as a biotechnological tool for amplifying the yield and bioactivity of secondary metabolites in E. camaldulensis.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.